The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Transplant recipients must take anti-rejection medications in order to suppress their immune system and prevent rejection of the new organ. A suppressed immune system results in a higher risk of getting infections and having more difficulties in fighting against them. Anti-rejection medications may prevent the body from responding well to vaccines. While minor infections are common after a transplant, they can become serious if the patient has other chronic conditions, which can increase the risks of infection, including lung disease, heart disease, or diabetes.
This webinar aims to increase patient awareness against the risks of infectious diseases through talks by experienced patient advocates and empower them to address their concerns with their healthcare professionals.
Learning Objectives:
After attending this webinar, participants will learn:
For more information on ESOT’s Patient advocacy and awareness project, please click here.
Scientific Organisers:
Scientific Programme available here.
Note: Participants will be able to make use of simultaneous subtitles to translate the webinar in the language of their choice.
This activity has been developed under a healthcare collaboration between the European Society for Organ Transplantation (ESOT) and Takeda that aims to benefit patient care. All content has been developed independently by ESOT.
Surgeons, nurses, physicians, caregives, patient advocates
Moderator: Penilla Gunther (Sweden); Bill Scott (UK)
| 17:30 | Welcome | 5 min | Bill Scott (UK) |
| 17:35 | Session 1 – Patient Empowerment
What do patients want? Drug adherence. Being heard. What are the challenges to overcome? |
10 min | Penilla Gunther (Sweden) |
| 17:45 | Session 2 – Infectious disease (CMV)
How does a patient feel when they get ‘really’ sick? |
10 min | Fiona Loud (UK) |
| 17:55 | My Life – my health – tools to communicate your health concerns | 10 min | Penilla Gunther (Sweden);
Luciano Potena (Italy) |
| 18:05 | Session 3 – Panel discussion | 25 min | Moderator: Bill Scott
Panel – Penilla Gunther (Sweden – Heart); Fiona Loud (UK – Kidney); Liz Schick (Switzerland – Liver); Eric Epailly (Cardiologist – France); Saskia Bos (Pulmonologist – Belgium); Fernanda Ortiz (Nephrologist – Finland) |
| 18:29 | Concluding remarks | 1 min | Penilla Gunther (Sweden) |
